Pradyumna Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 274.24%
- Profit Growth -548.57%
- Ebitda 116.90%
- Net Worth -107.74%
- Total Assets 18.93%
About Pradyumna Pharma Distributors
Pradyumna Pharma Distributors Private Limited (PPDPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2018 (Six years and four months 27 days old ). Its registered office is in Kolar, Karnataka, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nootve Asha, Shivaram Gowda, Bathalahalli Babu, and Two other members serve as directors at the Company.
Company Details
-
Location
Kolar, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909KA2018PTC116530
-
Company No.
116530
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Sep 2018
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Pradyumna Pharma Distributors?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nootve Asha
|
Director | 20-Sep-2018 | Current |
|
Shivaram Gowda
|
Director | 20-Sep-2018 | Current |
|
Bathalahalli Babu
|
Director | 20-Sep-2018 | Current |
|
Manjunatha Subbarayappa
|
Director | 20-Sep-2018 | Current |
|
Prema Muniyappa
|
Director | 20-Sep-2018 | Current |
Financial Performance of Pradyumna Pharma Distributors.
Pradyumna Pharma Distributors Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 274.24% increase. The company also saw a substantial fall in profitability, with a 548.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 107.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pradyumna Pharma Distributors?
Unlock access to Pradyumna Pharma Distributors's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pradyumna Pharma Distributors?
Unlock and access historical data on people associated with Pradyumna Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pradyumna Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pradyumna Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.